GELS

0.17% -0.001

アフターアワーズ： .58

Gelteq Ltd (GELS)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Gelteq Ltd Stock (GELS) Company Profile

Healthcare (1080)

GELS's Discussions on Twitter

Compare GELS vs TAK, TEVA, HLN, ZTS, UTHR

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
GELS Gelteq Ltd	0.58	6.11M	0	0	0	-0.3691
TAK Takeda Pharmaceutical Co Adr	17.63	55.60B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.77	42.81B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.70	43.16B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	73.79	30.39B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	499.73	21.95B	3.17B	1.29B	1.01B	27.09

Gelteq Ltd (GELS) 最新ニュース

Gelteq Ltd (GELS) 財務データ

Gelteq Ltd (GELS)

Gelteq Ltd Stock (GELS) Company Profile

Compare GELS vs TAK, TEVA, HLN, ZTS, UTHR

Gelteq Ltd (GELS) 最新ニュース

Gelteq Ltd (GELS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Gelteq Ltd (GELS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Gelteq Ltd (GELS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

GELS|Gelteq Ltd|Price:0.670|Chg%:-0.031 - TradingKey

Gelteq Ltd (GELS) Balance Sheet - TradingKey

Gelteq Ltd (GELS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Gelteq Ltd (GELS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Gelteq Ltd (GELS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Gelteq Ltd (GELS) Cash Flow - TradingKey

Gelteq Ltd (GELS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Gelteq Ltd (GELS) Institutional Confidence - TradingKey

Gelteq Ltd (GELS) Income Statement - TradingKey

GELS|Gelteq Ltd|Price:0.701|Chg%:-0.042 - TradingKey

Gelteq | 3: Initial statement of beneficial ownership of securities- Givoni Nathan J - Moomoo

Gelteq | 3: Initial statement of beneficial ownership of securities- Karp Bradley Glenn - Moomoo

Gelteq (GELS) wins shareholder approval and closes $2.5M second tranche note - Stock Titan

GELSGelteq Ltd Short Interest - Finviz

Gelteq (GELS) faces $5.3M working capital deficit and rising debt - Stock Titan

Gelteq Company Profile & Introduction - Moomoo

Gelteq Ltd (GELS) Valuation: PE, PB & Fair Value Analysis - TradingKey

Gelteq advances clinical programs across pharmaceutical and veterinary applications By Investing.com - Investing.com India

Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs - The Manila Times

Gelteq lines up first human trial, vet study and $3.5M financing - Stock Titan

GELS Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade

10 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

$Gelteq (GELS.US)$ thank you - Moomoo

Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications - The Manila Times

What's Going On With Gelteq Stock Friday?Gelteq (NASDAQ:GELS) - Benzinga

Dogs accept gels that hide bitter medicine, Gelteq trials show - Stock Titan

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

$Gelteq (GELS.US)$ 👍 sold all already. thank you![Drool][Cool Guy][Rich][Peace][Blessing] - Moomoo

Gelteq establishes Centre of Excellence in China to accelerate product development - BioSpectrum Asia

Gelteq establishes center of excellence in China’s Guangdong By Investing.com - Investing.com South Africa

Gelteq establishes center of excellence in China’s Guangdong - Investing.com

Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion - The Manila Times

Gelteq sets up Guangdong hub as China biotech deals near $60B - Stock Titan

Gelteq Limited announced that it expects to receive $3.5 million in funding - marketscreener.com

Gelteq (GELS) calls Special Meeting on convertible note share issuance and 9.99% cap - Stock Titan

Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities - MSN

Gelteq secures up to $3.5 million in convertible debt financing By Investing.com - Investing.com India

Gelteq secures up to $3.5 million in convertible debt financing - Investing.com

Gelteq (NASDAQ: GELS) inks up to $3.5M structured convertible note deal - Stock Titan

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Gelteq begins clinical trial for veterinary antiparasitic drug - Investing.com

Gelteq begins clinical trial for veterinary antiparasitic drug By Investing.com - Investing.com South Africa

Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway - The Manila Times

Inside Gelteq’s first vet drug trial in a $78B animal health market - Stock Titan

Gelteq Ltd (GELS) 財務データ

収益

当期純利益

現金流量

EPS

GELSに似た銘柄